**Core Concept**
Laryngeal spasm during intubation is a clinical phenomenon characterized by involuntary contractions of the laryngeal muscles, leading to respiratory obstruction. The prevention of this condition is crucial for maintaining a secure airway during intubation.

**Why the Correct Answer is Right**
Laryngeal spasm is often induced by the stimulation of the laryngeal mucosa, which triggers the release of histamine and other mediators. To prevent this, drugs that counteract histamine and other mediators can be used. These include anticholinergics, which block the action of acetylcholine at muscarinic receptors, thereby reducing laryngeal secretions and muscle contractions. **Atropine** and **glycopyrrolate** are examples of anticholinergics used for this purpose. Other options, such as **succinylcholine**, can also help prevent laryngeal spasm by providing a brief paralysis of the muscles involved in the spasm.

**Why Each Wrong Option is Incorrect**
**Option A:** Succinylcholine is actually used to prevent laryngeal spasm, so this option is incorrect.
**Option B:** Atropine is an anticholinergic that helps prevent laryngeal spasm, making this option incorrect.
**Option C:** Glycopyrrolate is also an anticholinergic used to prevent laryngeal spasm, so this option is incorrect.

**Clinical Pearl / High-Yield Fact**
Mnemonic to remember: "ATG" for Atropine, Glycopyrrolate, and Succinylcholine, which are all used to prevent laryngeal spasm during intubation.

**Correct Answer:** A. Succinylcholine is not typically used to prevent laryngeal spasm, but rather to induce muscle paralysis.